Literature DB >> 25501507

MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2.

Zhong-Liang Ma1, Pin-Pin Hou, Yan-Li Li, De-Tao Wang, Tian-Wei Yuan, Jia-Li Wei, Bo-Tao Zhao, Jia-Tao Lou, Xin-Tai Zhao, Yan Jin, You-Xin Jin.   

Abstract

MicroRNAs (MiRNAs) are small non-coding RNA molecules which act as important regulators of post-transcriptional gene expression by binding 3'-untranslated region (3'-UTR) of target messenger RNA (mRNA). In this study, we analyzed miRNA-34a (miR-34a) as a tumor suppressor in non-small cell lung cancer (NSCLC) H1299 cell line. The expression level of miR-34a in four different NSCLC cell lines, H1299, A549, SPCA-1, and HCC827, was significantly lower than that in the non-tumorigenic bronchial epithelium cell line BEAS-2B. In human NSCLC tissues, miR-34a expression level was also significantly decreased in pT2-4 compared with the pT1 group. Moreover, miR-34a mimic could inhibit the proliferation and triggered apoptosis in H1299 cells. Luciferase assays revealed that miR-34a inhibited TGFβR2 expression by targeting one binding site in the 3'-UTR of TGFβR2 mRNA. Quantitative real-time PCR (qRT-PCR) and Western blot assays verified that miR-34a reduced TGFβR2 expression at both mRNA and protein levels. Furthermore, downregulation of TGFβR2 by siRNA showed the same effects on the proliferation and apoptosis as miR-34a mimic in H1299 cells. Our results demonstrated that miR-34a could inhibit the proliferation and promote the apoptosis of H1299 cells partially through the downregulation of its target gene TGFβR2.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25501507     DOI: 10.1007/s13277-014-2861-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  44 in total

1.  miRNA expression profiling: from reference genes to global mean normalization.

Authors:  Barbara D'haene; Pieter Mestdagh; Jan Hellemans; Jo Vandesompele
Journal:  Methods Mol Biol       Date:  2012

2.  miRNA expression profiling using Illumina Universal BeadChips.

Authors:  Jing Chen; Craig S April; Jian-Bing Fan
Journal:  Methods Mol Biol       Date:  2012

3.  Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.

Authors:  Jason F Wiggins; Lynnsie Ruffino; Kevin Kelnar; Michael Omotola; Lubna Patrawala; David Brown; Andreas G Bader
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

4.  Morphometry confirms the presence of considerable nuclear size overlap between "small cells" and "large cells" in high-grade pulmonary neuroendocrine neoplasms.

Authors:  A M Marchevsky; A A Gal; S Shah; M N Koss
Journal:  Am J Clin Pathol       Date:  2001-10       Impact factor: 2.493

Review 5.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  Identification of nuclear structural protein alterations associated with seminomas.

Authors:  Eddy S Leman; Ahmed Magheli; Koh Meng Aw Yong; George Netto; Stefan Hinz; Robert H Getzenberg
Journal:  J Cell Biochem       Date:  2009-12-15       Impact factor: 4.429

8.  Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer.

Authors:  Stephan Gade; Christine Porzelius; Maria Fälth; Jan C Brase; Daniela Wuttig; Ruprecht Kuner; Harald Binder; Holger Sültmann; Tim Beissbarth
Journal:  BMC Bioinformatics       Date:  2011-12-21       Impact factor: 3.169

9.  miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.

Authors:  Nora Bandi; Erik Vassella
Journal:  Mol Cancer       Date:  2011-05-16       Impact factor: 27.401

10.  MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.

Authors:  Amanda Tivnan; Lorraine Tracey; Patrick G Buckley; Leah C Alcock; Andrew M Davidoff; Raymond L Stallings
Journal:  BMC Cancer       Date:  2011-01-25       Impact factor: 4.430

View more
  42 in total

1.  HMGI-C suppressing induces P53/caspase9 axis to regulate apoptosis in breast adenocarcinoma cells.

Authors:  Behzad Mansoori; Ali Mohammadi; Solmaz Shirjang; Behzad Baradaran
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

2.  MicroRNA-34a directly targets high-mobility group box 1 and inhibits the cancer cell proliferation, migration and invasion in cutaneous squamous cell carcinoma.

Authors:  Shanshan Li; Chengqun Luo; Jun Zhou; Yong Zhang
Journal:  Exp Ther Med       Date:  2017-10-02       Impact factor: 2.447

3.  MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.

Authors:  Wei Xu; Meng Hang; Chen-Ye Yuan; Fu-Lin Wu; Shu-Bo Chen; Kai Xue
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

4.  Predictive relevance of miR-34a, miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy.

Authors:  Vlastimil Kulda; Martin Svaton; Petr Mukensnabl; Kristyna Hrda; Pavel Dvorak; Zbynek Houdek; Katerina Houfkova; Radana Vrzakova; Vaclav Babuska; Milos Pesek; Martin Pesta
Journal:  Oncol Lett       Date:  2017-11-02       Impact factor: 2.967

Review 5.  MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.

Authors:  Qun Zhou; Shao-Xin Huang; Feng Zhang; Shu-Jun Li; Cong Liu; Yong-Yong Xi; Liang Wang; Xin Wang; Qi-Qiang He; Cheng-Cao Sun; De-Jia Li
Journal:  Cell Prolif       Date:  2017-10-08       Impact factor: 6.831

6.  MicroRNA-124 upregulation inhibits proliferation and invasion of osteosarcoma cells by targeting sphingosine kinase 1.

Authors:  Yan Zhou; Yanzhen Han; Zhitao Zhang; Zhe Shi; Liyuan Zhou; Xiaohong Liu; Xiaoyan Jia
Journal:  Hum Cell       Date:  2016-10-14       Impact factor: 4.374

7.  miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1).

Authors:  Zhiyuan Han; Yanbin Zhang; Qiaoyuan Yang; Binbin Liu; Jianjun Wu; Yajie Zhang; Chengfeng Yang; Yiguo Jiang
Journal:  Oncotarget       Date:  2015-05-30

Review 8.  MiRNA-based therapeutic intervention of cancer.

Authors:  Srivatsava Naidu; Peter Magee; Michela Garofalo
Journal:  J Hematol Oncol       Date:  2015-06-11       Impact factor: 17.388

9.  MicroRNA-486-5p Suppresses Lung Cancer via Downregulating mTOR Signaling In Vitro and In Vivo.

Authors:  Lei Ding; Wu Tian; Hui Zhang; Wanqiu Li; Chunyu Ji; Yuanyuan Wang; Yanli Li
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

10.  RBMMMDA: predicting multiple types of disease-microRNA associations.

Authors:  Xing Chen; Chenggang Clarence Yan; Xiaotian Zhang; Zhaohui Li; Lixi Deng; Yongdong Zhang; Qionghai Dai
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.